Plymouth Family Practice Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Warren St, Plymouth, NH 03264 Phone: 603-536-2502 Fax: 603-536-2503 |
Mid-state Health Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 28 Main St, Plymouth, NH 03264 Phone: 603-536-4000 |
Plymouth Pediatric And Adolescent Medicine Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 71 Highland St, Plymouth, NH 03264 Phone: 603-536-3700 Fax: 603-536-5384 |
Speare Hospitalist Program General Practice Medicare: Medicare Enrolled Practice Location: 16 Hospital Rd, Plymouth, NH 03264 Phone: 603-536-1120 |
Speare Memorial Hospital Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 16 Hospital Rd, Plymouth, NH 03264 Phone: 603-536-1104 Fax: 603-536-7260 |
Gennaro Family Practice Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16 Hospital Rd, Plymouth, NH 03264 Phone: 603-536-1120 |
Mid-state Health Center Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Boulder Point Dr, Suite 1, Plymouth, NH 03264 Phone: 603-536-4000 Fax: 603-536-4001 |
Speare Memorial Hospital Family Medicine Medicare: Medicare Enrolled Practice Location: 103 Boulder Point Drive, Plymouth, NH 03264 Phone: 603-536-1881 Fax: 603-238-2198 |
Mid-state Health Center Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 607 Tenney Mountain Hwy Ste 144, Plymouth, NH 03264 Phone: 603-536-4000 Fax: 603-536-4001 |
News Archive
An ophthalmologist at UT Southwestern Medical Center has helped create a convenient device that lets patients who have a degenerative eye disease better track vision changes.
In mice that are given a high-fat diet, an increased production of the enzyme DPP4 by the liver promotes an increase in body fat, the development of fatty liver disease and insulin resistance.
Merus Labs International Inc. is pleased to announce that effective at the open of market on Thursday, September 16, 2010, Merus' shares will begin trading on the Canadian National Stock Exchange ("CNSX") under the trading symbol MR. The shares will be quoted on the CNSX in Canadian currency.
When investigators compared initial bone parameters with changes in those parameters over time in postmenopausal women, they found that initial measurements were significantly associated with women's risk of fracture.
Health Diagnostic Laboratory Inc., a CAP accredited leader in health management, announced today that it will expand its comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases through the acquisition of Harris Scientific, Inc., a company providing omega-3 fatty acid testing based on the research of Dr. William Harris.
› Verified 2 days ago